Exenatide add-on for patients with uncontrolled type 2 diabetes despite intensive insulin therapy: Phase-2 results of the randomized exepump trial

Authors
Category Primary study
ConferenceDiabetes Technology and Therapeutics
Year 2015
This article has no abstract
Epistemonikos ID: 83210bae03b5cff75b9e200305c065625a3e8d7d
First added on: Apr 30, 2026